Abstract
Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer: Epithelial Mesenchymal Transition (EMT), the Missing Link?
Highlights
Lung cancer and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and the presence of COPD increases the risk of developing lung cancer by 4–5 folds, even when the smoking history is controlled for (Sohal et al, 2014a; Sohal et al, 2013)
In a recent very comprehensive study by Huang and colleagues published in EBioMedicine, provided compelling evidence suggesting strong association between smoking, COPD and small cell lung cancer (SCLC) (Huang et al, 2015)
Potential shared biological mechanisms in COPD and lung cancer include: chronic inflammation, matrix degradation, cell proliferation and anti-apoptosis, abnormal wound repair and angiogenesis, but perhaps especially the process of epithelial mesenchymal transition (EMT), a highly plastic process in which epithelial cells change into a mesenchymal phenotype (Yang et al, 2011)
Summary
Lung cancer and chronic obstructive pulmonary disease (COPD) commonly coexist in smokers, and the presence of COPD increases the risk of developing lung cancer by 4–5 folds, even when the smoking history is controlled for (Sohal et al, 2014a; Sohal et al, 2013). In a recent very comprehensive study by Huang and colleagues published in EBioMedicine, provided compelling evidence suggesting strong association between smoking, COPD and small cell lung cancer (SCLC) (Huang et al, 2015).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.